This story has been updated to include information from a conference call to discuss Quidel's earnings.

NEW YORK (GenomeWeb) – Diagnostics manufacturer Quidel reported after the close of the market on Wednesday that its fourth quarter revenues rose approximately 1 percent year over year, due largely to higher sales of immunoassay, molecular, and specialty products.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.